Filing Details
- Accession Number:
- 0000945769-10-000011
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-04-09 13:00:00
- Reporting Period:
- 2010-04-07
- Filing Date:
- 2010-04-09
- Accepted Time:
- 2010-04-09 13:54:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 887497 | Hi Tech Pharmacal Co Inc | HITK | Pharmaceutical Preparations (2834) | 112638720 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1054694 | S David Seltzer | C/O Hi-Tech Pharmacal Co., Inc. 369 Bayview Avenue Amityville NY 11701 | Ceo, President, Sec'y, Treas. | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-04-07 | 25,000 | $22.52 | 1,204,620 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-04-08 | 25,000 | $22.58 | 1,179,620 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 221,402 | Indirect | By Spouse and Issue |
| Common Stock | 43,468 | Indirect | as Trustee of Trust |
| Common Stock | 46,144 | Indirect | as Trustee of Trust |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | $0.00 | 625,000 | 625,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 625,000 | 625,000 | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.30 to $22.77, inclusive. The reporting person undertakes to provide Hi-Tech Pharmacal Co., Inc., any security holder of Hi-Tech Pharmacal Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (1) and (2) of this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.45 to $22.78, inclusive.
- Stock Options granted under Hi-Tech Pharmacal Co., Inc.'s Amended and Restated Stock Option Plan, which is a Rule 16b-3 Plan
- Mr. Seltzer is the holder of options to acquire an aggregate of 625,000 additional shares of Hi-Tech Common Stock, which options were granted on various dates, with various exercise prices, exercise dates and expiration dates.
Billionaire Hedge Funds
